Open access · CC-BY
via OpenAlex
“Is dopamine involved in Alzheimer's disease?”
Alessandro Martorana, Giacomo Koch
Frontiers in Aging Neuroscience · 2014 · ▲ 275 citations
Abstract
Alzheimer's Disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline and dementia. Recent advances indicate that AD pathogenesis appears more complex than its mere neuropathology. Changes in synaptic plasticity, neuronal disarray and cell death are pathways commonly recognized as pathogenic mechanisms of AD. It is thought that the altered metabolism of certain membrane proteins may lead to the production of amyloid (Aβ) oligomers that are characterized by an highly toxic effect on neurotransmission pathways, such as those mediated by Acetylcholine. The interaction of Aβ oligomers with these neurotansmitters systems would in turn induce cell dysfunction, neurotransmitters signaling imbalance and finally lead to the appearance of neurological signs. In this perspective, it is still debated how and if these mechanisms may also engage the dopaminergic system in AD. Recent experimental work revealed that the dopaminergic system may well be involved in the occurrence of cognitive decline, often being predictive of rapidly progressive forms of AD. However, a clear idea on the role of the dopamine system in AD is still missing. Here we review the more recent evidences supporting the notion that the dopaminergic dysfunction has a pathogenic role in cognitive decline symptoms of AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fnagi.2014.00252
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Martorana, A., & Koch, G. (2014). “Is dopamine involved in Alzheimer's disease?”. <em>Frontiers in Aging Neuroscience</em>. https://doi.org/10.3389/fnagi.2014.00252
Vancouver
Martorana A, Koch G. “Is dopamine involved in Alzheimer's disease?”. Frontiers in Aging Neuroscience. 2014. doi:10.3389/fnagi.2014.00252.
BibTeX
@article{alessandro2014Isdopa,
title = {“Is dopamine involved in Alzheimer's disease?”},
author = {Alessandro Martorana and Giacomo Koch},
journal = {Frontiers in Aging Neuroscience},
year = {2014},
doi = {10.3389/fnagi.2014.00252},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Mechanisms of Ageing and Development 2026
Citation only
Loss of Ca2 + signaling fidelity during aging: Mitochondrial dysfunction, senescence, and cognitive–motor decline
2014
Citation only
Cerebral ageing-the role of insulin and insulin-like growth factor signalling:A review
Experimental Cell Research 2021
Open access · CC-BY
The aging proteostasis decline: From nematode to human
Archivum Immunologiae et Therapiae Experimentalis 2012
Preprint · OA
The Classification of Microglial Activation Phenotypes on Neurodegeneration and Regeneration in Alzheimer’s Disease Brain
Frontiers in bioscience 2006
Open access · OA
Mitochondrial dysfunction in human pathologies
Current Protein and Peptide Science 2018
Citation only